CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...